Literature DB >> 24852051

Antigens for CD4 and CD8 T cells in tuberculosis.

Cecilia S Lindestam Arlehamn1, David Lewinsohn2, Alessandro Sette1, Deborah Lewinsohn3.   

Abstract

Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis (MTB), represents an important cause of morbidity and mortality worldwide for which an improved vaccine and immunodiagnostics are urgently needed. CD4(+) and CD8(+) T cells play an important role in host defense to TB. Definition of the antigens recognized by these T cells is critical for improved understanding of the immunobiology of TB and for development of vaccines and diagnostics. Herein, the antigens and epitopes recognized by classically HLA class I- and II-restricted CD4(+) and CD8(+) T cells in humans infected with MTB are reviewed. Immunodominant antigens and epitopes have been defined using approaches targeting particular TB proteins or classes of proteins and by genome-wide discovery approaches. Antigens and epitopes recognized by classically restricted CD4(+) and CD8(+) T cells show extensive breadth and diversity in MTB-infected humans.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24852051      PMCID: PMC4066646          DOI: 10.1101/cshperspect.a018465

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  154 in total

1.  Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.

Authors:  L A van Pinxteren; P Ravn; E M Agger; J Pollock; P Andersen
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

Authors:  A Baena; S A Porcelli
Journal:  Tissue Antigens       Date:  2009-06-25

3.  CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool.

Authors:  J P Rosat; E P Grant; E M Beckman; C C Dascher; P A Sieling; D Frederique; R L Modlin; S A Porcelli; S T Furlong; M B Brenner
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

4.  Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.

Authors:  Susanna Commandeur; May Y Lin; Krista E van Meijgaarden; Annemieke H Friggen; Kees L M C Franken; Jan W Drijfhout; Gro E Korsvold; Fredrik Oftung; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Eur J Immunol       Date:  2011-08-30       Impact factor: 5.532

5.  Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: consequences for immune recognition.

Authors:  Rebecca Axelsson-Robertson; Raija K Ahmed; Frank F Weichold; Marthie M Ehlers; Marleen M Kock; Donata Sizemore; Jerry Sadoff; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

6.  Molecular determinants of T cell epitope recognition to the common Timothy grass allergen.

Authors:  Carla Oseroff; John Sidney; Maya F Kotturi; Ravi Kolla; Rafeul Alam; David H Broide; Stephen I Wasserman; Daniela Weiskopf; Denise M McKinney; Jo L Chung; Arnd Petersen; Howard Grey; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

7.  Rationally engineered therapeutic proteins with reduced immunogenicity.

Authors:  Shabnam Tangri; Bianca R Mothé; Julie Eisenbraun; John Sidney; Scott Southwood; Kristen Briggs; John Zinckgraf; Pamuk Bilsel; Mark Newman; Robert Chesnut; Cynthia Licalsi; Alessandro Sette
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

8.  Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies.

Authors:  Hiwa Målen; Frode S Berven; Tina Søfteland; Magnus Øverlie Arntzen; Clive S D'Santos; Gustavo Antonio De Souza; Harald G Wiker
Journal:  Proteomics       Date:  2008-05       Impact factor: 3.984

Review 9.  Lessons from experimental Mycobacterium tuberculosis infections.

Authors:  JoAnne L Flynn
Journal:  Microbes Infect       Date:  2006-01-18       Impact factor: 2.700

10.  Eliminating latent tuberculosis.

Authors:  Douglas B Young; Hannah P Gideon; Robert J Wilkinson
Journal:  Trends Microbiol       Date:  2009-04-16       Impact factor: 17.079

View more
  27 in total

1.  A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.

Authors:  Chelsea Carpenter; John Sidney; Ravi Kolla; Kaustuv Nayak; Helena Tomiyama; Claudia Tomiyama; Oscar A Padilla; Virginie Rozot; Syed F Ahamed; Carlos Ponte; Valeria Rolla; Paulo R Antas; Anmol Chandele; John Kenneth; Seetha Laxmi; Edward Makgotlho; Valentina Vanini; Giuseppe Ippolito; Alexandra S Kazanova; Alexander V Panteleev; Willem Hanekom; Harriet Mayanja-Kizza; David Lewinsohn; Mayuko Saito; M Juliana McElrath; W Henry Boom; Delia Goletti; Robert Gilman; Irina V Lyadova; Thomas J Scriba; Esper G Kallas; Kaja Murali-Krishna; Alessandro Sette; Cecilia S Lindestam Arlehamn
Journal:  Tuberculosis (Edinb)       Date:  2015-08-01       Impact factor: 3.131

Review 2.  Do HLA class II genes protect against pulmonary tuberculosis? A systematic review and meta-analysis.

Authors:  A Oliveira-Cortez; A C Melo; V E Chaves; A Condino-Neto; P Camargos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-13       Impact factor: 3.267

3.  Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.

Authors:  Mangalakumari Jeyanathan; Daniela Damjanovic; Yushi Yao; Jonathan Bramson; Fiona Smaill; Zhou Xing
Journal:  J Infect Dis       Date:  2016-10-04       Impact factor: 5.226

Review 4.  Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

Authors:  Kevin B Urdahl
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

Review 5.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

6.  Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4+ T Cells.

Authors:  Alison J Johnson; Steven C Kennedy; Cecilia S Lindestam Arlehamn; Michael F Goldberg; Neeraj K Saini; Jiayong Xu; Sinu Paul; Subray S Hegde; John S Blanchard; John Chan; William R Jacobs; Alessandro Sette; Steven A Porcelli
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

7.  The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.

Authors:  Bianca R Mothé; Cecilia S Lindestam Arlehamn; Courtney Dow; Myles B C Dillon; Roger W Wiseman; Patrick Bohn; Julie Karl; Nadia A Golden; Trey Gilpin; Taylor W Foreman; Mark A Rodgers; Smriti Mehra; Thomas J Scriba; JoAnne L Flynn; Deepak Kaushal; David H O'Connor; Alessandro Sette
Journal:  Tuberculosis (Edinb)       Date:  2015-08-28       Impact factor: 3.131

Review 8.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

9.  Balance between Protection and Pathogenic Response to Aerosol Challenge with Mycobacterium tuberculosis (Mtb) in Mice Vaccinated with TriFu64, a Fusion Consisting of Three Mtb Antigens.

Authors:  Sadaf Sulman; Benjamin O Savidge; Kawther Alqaseer; Mrinal K Das; Neda Nezam Abadi; John E Pearl; Obolbek Turapov; Galina V Mukamolova; M Waheed Akhtar; Andrea May Cooper
Journal:  Vaccines (Basel)       Date:  2021-05-18

10.  A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection.

Authors:  Wendy E Whatney; Neel R Gandhi; Cecilia S Lindestam Arlehamn; Azhar Nizam; Hao Wu; Melanie J Quezada; Angela Campbell; Salim Allana; Mbuyi Madeleine Kabongo; Jeremiah Khayumbi; Benson Muchiri; Joshua Ongalo; Joan Tonui; Loren E Sasser; Tawania J Fergus; Gregory Sadat Ouma; Samuel Gurrion Ouma; Allison A Beck; Mark J Mulligan; Alawode Oladele; Deepak Kaushal; Kevin P Cain; Lance Waller; Henry M Blumberg; John D Altman; Joel D Ernst; Jyothi Rengarajan; Cheryl L Day
Journal:  J Immunol       Date:  2018-03-14       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.